This page shows the latest emtricitabine news and features for those working in and with pharma, biotech and healthcare.
Without the Veklury bump, total product sales decreased by 3% to $5.4bn for the third quarter, primarily due to the loss of exclusivity of HIV combination therapies Truvada (emtricitabine/tenofovir ... The drop was also partially offset by a 20% increase
Gilead has attributed the Q4 decrease to lower sales of its Truvada (emtricitabine/tenofovir)-based products, given that the company lost exclusivity of Truvada and Atripla in the US in October
The PrEP Impact Trial is using Mylan's generic version of Gilead Sciences’ antiretroviral therapy Truvada (emtricitabine/tenofovir disoproxil) but is due to come to an end in October.
Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) product.
Descovy (emtricitabine/tenofovir alafenamide) claimed its FDA approval for PrEP last week – becoming only the second drug for this use since Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate) got a green
Treatments for HIV in particular have seen increasing advancements in recent years – other key players in this field are Gilead, whose next-generation HIV pre-exposure prophylaxis (PrEP) treatment Descovy (emtricitabine
More from news
Approximately 6 fully matching, plus 77 partially matching documents found.
11. Lamivudine or emtricitabine – nucleoside reverse transcriptase inhibitors (NRTIs). 12.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...